Nesfatin-1 and other hormone alterations in polycystic ovary syndrome

dc.contributor.author	Deniz, Rulin
dc.contributor.author	Gurates, Bilgin
dc.contributor.author	Aydin, Suleyman
dc.contributor.author	Celik, Husnu
dc.contributor.author	Sahin, Ibrahim
dc.contributor.author	Baykus, Yakup
dc.contributor.author	Catak, Zekiye
dc.contributor.author	Aksoy, Aziz
dc.date.accessioned	16/12/21 12:08
dc.date.available	16/12/21 12:08
dc.date.issued	2012
dc.identifier.issn	1355-008X
dc.identifier.uri	http://dspace.beu.edu.tr:8080/xmlui/handle/20.500.12643/10706
dc.identifier.uri	https://doi.org/10.1007/s12020-012-9638-7
dc.description.abstract	Polycystic ovary syndrome (PCOS) is commonly characterised by obesity, insulin resistance (IR), hyperandrogenemia and hirsutism. Nesfatin-1 a recently discovered hormone, acts upon energy balance, glucose metabolism, obesity and probably gonadal functions
dc.description.sponsorship	FUBAPFirat University [1889]
dc.language.iso	English
dc.publisher	Sprınger
dc.source	Endocrıne
dc.title	Nesfatin-1 and other hormone alterations in polycystic ovary syndrome
dc.type	Article
dc.identifier.issue	3
dc.identifier.startpage	694
dc.identifier.endpage	699
dc.identifier.doi	10.1007/s12020-012-9638-7
dc.identifier.wos	WOS:000312073500034
dc.identifier.volume	42

Files in this item

Files	Size	Format	View
There are no files associated with this item.